Literature DB >> 25646064

Recurred adenoid cystic carcinoma of lacrimal gland with aggressive local invasion to the maxillary bone marrow without increased uptake in PET-CT.

Moonjung Choi1, Ja Seung Koo2, Jin Sook Yoon1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25646064      PMCID: PMC4309872          DOI: 10.3341/kjo.2015.29.1.68

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


× No keyword cloud information.
  4 in total

1.  Disease recurrence after intraarterial chemotherapy in 2 patients with adenoid cystic carcinoma of lacrimal gland.

Authors:  Melissa Fellman; Keith Carter; Conley B Call; Bita Esmaeli
Journal:  Can J Ophthalmol       Date:  2013-04       Impact factor: 1.882

2.  Adenoid cystic carcinoma of the lacrimal gland: CT and MRI findings.

Authors:  Wei Qin; Robert Chong; Xuequan Huang; Mingming Liu; Zheng Qin Yin
Journal:  Eur J Ophthalmol       Date:  2012 May-Jun       Impact factor: 2.597

3.  Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma.

Authors:  David T Tse; Andrea L Kossler; William J Feuer; Pasquale W Benedetto
Journal:  Ophthalmology       Date:  2013-04-09       Impact factor: 12.079

4.  Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland.

Authors:  Bita Esmaeli; M Amir Ahmadi; Adel Youssef; Roxana Diba; Malena Amato; Jeffrey N Myers; Merrill Kies; Adel El-Naggar
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2004-01       Impact factor: 1.746

  4 in total
  1 in total

1.  A pilot study of 68 Ga-PSMA-617 PET/CT imaging and 177Lu-EB-PSMA-617 radioligand therapy in patients with adenoid cystic carcinoma.

Authors:  Guochang Wang; Mengjiao Zhou; Jie Zang; Yuanyuan Jiang; Xiaohong Chen; Zhaohui Zhu; Xiaoyuan Chen
Journal:  EJNMMI Res       Date:  2022-08-19       Impact factor: 3.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.